Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

CRISPR-Associated Primase-Polymerases are implicated in prokaryotic CRISPR-Cas adaptation

K. Zabrady, M. Zabrady, P. Kolesar, AWH. Li, AJ. Doherty

. 2021 ; 12 (1) : 3690. [pub] 20210617

Language English Country Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Grant support
BB/F013795/1 Biotechnology and Biological Sciences Research Council - United Kingdom
BB/J018643/1 Biotechnology and Biological Sciences Research Council - United Kingdom
BB/M004236/1 Biotechnology and Biological Sciences Research Council - United Kingdom

CRISPR-Cas pathways provide prokaryotes with acquired "immunity" against foreign genetic elements, including phages and plasmids. Although many of the proteins associated with CRISPR-Cas mechanisms are characterized, some requisite enzymes remain elusive. Genetic studies have implicated host DNA polymerases in some CRISPR-Cas systems but CRISPR-specific replicases have not yet been discovered. We have identified and characterised a family of CRISPR-Associated Primase-Polymerases (CAPPs) in a range of prokaryotes that are operonically associated with Cas1 and Cas2. CAPPs belong to the Primase-Polymerase (Prim-Pol) superfamily of replicases that operate in various DNA repair and replication pathways that maintain genome stability. Here, we characterise the DNA synthesis activities of bacterial CAPP homologues from Type IIIA and IIIB CRISPR-Cas systems and establish that they possess a range of replicase activities including DNA priming, polymerisation and strand-displacement. We demonstrate that CAPPs operonically-associated partners, Cas1 and Cas2, form a complex that possesses spacer integration activity. We show that CAPPs physically associate with the Cas proteins to form bespoke CRISPR-Cas complexes. Finally, we propose how CAPPs activities, in conjunction with their partners, may function to undertake key roles in CRISPR-Cas adaptation.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21025566
003      
CZ-PrNML
005      
20211026133708.0
007      
ta
008      
211013s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41467-021-23535-9 $2 doi
035    __
$a (PubMed)34140468
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Zabrady, Katerina $u Genome Damage and Stability Centre, School of Life Sciences, University of Sussex, Brighton, UK
245    10
$a CRISPR-Associated Primase-Polymerases are implicated in prokaryotic CRISPR-Cas adaptation / $c K. Zabrady, M. Zabrady, P. Kolesar, AWH. Li, AJ. Doherty
520    9_
$a CRISPR-Cas pathways provide prokaryotes with acquired "immunity" against foreign genetic elements, including phages and plasmids. Although many of the proteins associated with CRISPR-Cas mechanisms are characterized, some requisite enzymes remain elusive. Genetic studies have implicated host DNA polymerases in some CRISPR-Cas systems but CRISPR-specific replicases have not yet been discovered. We have identified and characterised a family of CRISPR-Associated Primase-Polymerases (CAPPs) in a range of prokaryotes that are operonically associated with Cas1 and Cas2. CAPPs belong to the Primase-Polymerase (Prim-Pol) superfamily of replicases that operate in various DNA repair and replication pathways that maintain genome stability. Here, we characterise the DNA synthesis activities of bacterial CAPP homologues from Type IIIA and IIIB CRISPR-Cas systems and establish that they possess a range of replicase activities including DNA priming, polymerisation and strand-displacement. We demonstrate that CAPPs operonically-associated partners, Cas1 and Cas2, form a complex that possesses spacer integration activity. We show that CAPPs physically associate with the Cas proteins to form bespoke CRISPR-Cas complexes. Finally, we propose how CAPPs activities, in conjunction with their partners, may function to undertake key roles in CRISPR-Cas adaptation.
650    _2
$a Bacteria $x enzymologie $x genetika $7 D001419
650    _2
$a bakteriální proteiny $x genetika $x metabolismus $7 D001426
650    _2
$a Bacteroidetes $x enzymologie $x genetika $7 D041963
650    _2
$a Cas proteiny $x metabolismus $7 D064130
650    12
$a CRISPR-Cas systémy $7 D064113
650    _2
$a výpočetní biologie $7 D019295
650    _2
$a DNA-primasa $x genetika $x metabolismus $7 D019915
650    _2
$a DNA primery $x biosyntéza $7 D017931
650    _2
$a DNA-dependentní DNA-polymerasy $x genetika $x metabolismus $7 D004259
650    _2
$a dimerizace $7 D019281
650    _2
$a Escherichia coli $x metabolismus $7 D004926
650    _2
$a exprese genu $7 D015870
650    _2
$a mutace $7 D009154
650    _2
$a fylogeneze $7 D010802
650    _2
$a prokaryotické buňky $x metabolismus $7 D011387
650    _2
$a rekombinantní proteiny $7 D011994
650    _2
$a ribonukleotidy $x metabolismus $7 D012265
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Zabrady, Matej $u Genome Damage and Stability Centre, School of Life Sciences, University of Sussex, Brighton, UK
700    1_
$a Kolesar, Peter $u Genome Damage and Stability Centre, School of Life Sciences, University of Sussex, Brighton, UK $u National Centre for Biomolecular Research, Masaryk University, Brno, Czech Republic
700    1_
$a Li, Arthur W H $u Genome Damage and Stability Centre, School of Life Sciences, University of Sussex, Brighton, UK
700    1_
$a Doherty, Aidan J $u Genome Damage and Stability Centre, School of Life Sciences, University of Sussex, Brighton, UK. ajd21@sussex.ac.uk
773    0_
$w MED00184850 $t Nature communications $x 2041-1723 $g Roč. 12, č. 1 (2021), s. 3690
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34140468 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20211026133714 $b ABA008
999    __
$a ok $b bmc $g 1714563 $s 1146073
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 12 $c 1 $d 3690 $e 20210617 $i 2041-1723 $m Nature communications $n Nat Commun $x MED00184850
GRA    __
$a BB/F013795/1 $p Biotechnology and Biological Sciences Research Council $2 United Kingdom
GRA    __
$a BB/J018643/1 $p Biotechnology and Biological Sciences Research Council $2 United Kingdom
GRA    __
$a BB/M004236/1 $p Biotechnology and Biological Sciences Research Council $2 United Kingdom
LZP    __
$a Pubmed-20211013

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...